Lv51
1510 积分 2024-02-29 加入
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
34分钟前
待确认
Cancer burden and control in China: landscape, trends and challenges
52分钟前
已完结
Zanidatamab vs trastuzumab with or without PD-1 blockade in HER2-positive metastatic gastric cancer: a reconstructed patient-level pooled analysis
12天前
已完结
Biological mechanism and immune response of MHC-II expression in tumor cells
21天前
已完结
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
1个月前
已完结
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
1个月前
已完结
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
1个月前
已完结
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates
1个月前
已完结
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
1个月前
已完结
Complement: a key system for immune surveillance and homeostasis
1个月前
已完结
皖公网安备34019202002308
